193 / 256
65
[Trastornos del sueño en la adolescencia - Dra. Francesca Solari B.]
REFERENCias bibliográficas
1.
Kuhna B. Elliottb, A. Treatment efficacy in behavioral pediatric sleep
medicine Journal Psyc Res 54 (2003) 587-597).
2.
Owens, J. Classification and Epidemiology of Childhood Sleep Disorders
Prim Care Clin Office Pract 35 (2008) 533-546
3.
Hering E. Sleep patterns in autistic children. J Autism Dev Disord 1999; 29:
143-147
4.
Dewald, J. F., Meijer, A. M., Oort, F. J., Kerkhof, G. A. and Bogels, S. M.
The influence of sleep quality, sleep duration and sleepiness on school
performance in children and adolescents: a meta-analytic review. Sleep Med.
Rev., 2010, 14: 179-189
5.
Chesson AL Jr, Anderson WM, Littner M, et al. Practice parameters for the
nonpharmacologic treatment of chronic insomnia. An American Academy
of Sleep Medicine report. Standards of Practice Committee of the American
Academy of Sleep Medicine. Sleep 1999;22:1128-33.
6.
Roberts RE, Roberts CR, Chan W. Ethnic differences in symptoms of
insomnia among adolescents. Sleep 2006;29:359-65.
7.
Lewin, D Application of Cognitive Behavioral Therapy for
Insomnia in the Pediatric Population. Sleep Med Clin 9 (2014) 169-180
8.
Bonnet MH, Balkin TJ, Dinges DF, Roehrs T, Rogers NL, Wesensten NJ.
The use of stimulants to modify performance during sleep loss: a review by
the sleep deprivation and Stimulant Task Force of the American Academy of
Sleep Medicine.; Sleep Deprivation and Stimulant Task Force of the American
Academy of Sleep Medicine. Sleep. 2005 Sep;28(9):1163-87
9.
Dodson, E, Zee, P Therapeutics for Circadian Rhythm Sleep Disorders. Sleep
Med Clin 5 (2010) 701-715
10.
Dagan Y, Yovel I, Hallis D, et al. Evaluating the role of melatonin in the
long-term treatment of delayed sleep phase syndrome. Chronobiol Int 1998;
15(2):181e90
11.
Hood B , Harbord M. Narcolepsy: diagnosis and management in early
childhoodJ Pediatr Neurol 2004; 2(2):65-71).
12.
Silber MH, Rye DB. Posterior Hypothalamus, Alertness & Hypocretin
Neurology 2001; 56(12):1616
13.
Lin L, et al. The sleep disorder canine narcolepsy is caused by a mutation
in the hypocretin Cell 1999; 98: 365-376.
14.
Nishino S et al CSF Hypocretin-1 Levels. Neurology 2001; 57: 2253
15.
Mignot E; HLA DQB1*0602 is associated with cataplexy in 509 narcoleptic
patientsSleep 1997;
16.
Rogers AE Meehan, J. Guilleminault, C. Grumet, FC. Mignot, E; HLA
DR15 (DR2) and DQB1*0602 typing studies in 188 narcoleptic patients with
cataplexy Neurology June 1997 vol. 48 no. 6 1550-15561997
17.
Arand D, Bonnet M, Hurwitz T, Mitler M, Rosa R, Sangal RB ; A Review by
the MSLT and MWT Task Force of the Standards of Practice Committee of the
American Academy of Sleep Medicine. The Clinical Use of the MSLT and MWT
Sleep. 2005 Jan 1;28(1):123-4
La autora declara no tener conflictos de interés, en relación
a este artículo.